Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · IEX Real-Time Price · USD
11.51
-1.59 (-12.14%)
At close: May 28, 2024, 4:00 PM
11.50
-0.01 (-0.09%)
After-hours: May 28, 2024, 6:20 PM EDT
Avalo Therapeutics Stock Forecast
AVTX's stock price has decreased by -98.33% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Avalo Therapeutics stock have an average target of 107.5, with a low estimate of 35 and a high estimate of 180. The average target predicts an increase of 833.97% from the current stock price of 11.51.
Analyst Consensus: Buy
* Price targets were last updated on Apr 16, 2024.
Analyst Ratings
The average analyst rating for AVTX stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 1 | 1 |
Sell | 1 | 1 | 1 | 1 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Hold → Buy Upgrades $35 | Hold → Buy | Upgrades | $35 | +204.08% | Apr 16, 2024 |
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 27, 2023 |
RBC Capital | RBC Capital | Buy → Hold Downgrades $2,160 → $180 | Buy → Hold | Downgrades | $2,160 → $180 | +1,463.86% | Jun 27, 2023 |
RBC Capital | RBC Capital | Buy Maintains $4,080 → $2,160 | Buy | Maintains | $4,080 → $2,160 | +18,666.29% | May 10, 2023 |
Jefferies | Jefferies | Hold → Sell Downgrades $720 | Hold → Sell | Downgrades | $720 | +6,155.43% | Feb 8, 2023 |
Financial Forecast
Revenue This Year
n/a
from 1.92M
Revenue Next Year
n/a
EPS This Year
-0.93
from -114.00
EPS Next Year
-0.99
from -0.93
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | n/a | n/a |
Avg | n/a | n/a | n/a | n/a | n/a |
Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.96 | -1.02 | -1.08 |
Avg | -0.93 | -0.99 | -1.05 |
Low | -0.89 | -0.95 | -1.01 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.